(Q47849931)

6 February 2018

title

Development of antigen-specific T cells in mediastinal lymph nodes after intranasal immunization (English)

1 reference

6 February 2018

0 references

0 references

1

1 reference

6 February 2018

Donatella Negri

3

1 reference

6 February 2018

Antonella Riccomi

2

object named as

Antonella Riccomi

1 reference

6 February 2018

Maria Teresa De Magistris

6

object named as

Maria Teresa De Magistris

1 reference

6 February 2018

Filippo Veglia

4

object named as

Filippo Veglia

1 reference

6 February 2018

author name string

Ester Sciaraffia

5

1 reference

6 February 2018

publication date

6 May 2009

1 reference

6 February 2018

published in

Methods

1 reference

6 February 2018

volume

49

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

page(s)

334-339

1 reference

6 February 2018

Mucosal delivery of vaccine antigens and its advantages in pediatrics

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

NALT- versus Peyer's-patch-mediated mucosal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Early Events in Peripheral Regulatory T Cell Induction via the Nasal Mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Recent advances in mucosal vaccines and adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Mucosal immunisation: adjuvants and delivery systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Sublingual immunization induces broad-based systemic and mucosal immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Dynamics of Dendritic Cell Phenotype and Interactions with CD4+ T Cells in Airway Inflammation and Tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.018

10.1016/J.YMETH.2009.04.018

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018